The PPMI News page provides updates on the latest PPMI developments, including information on the progress of PD biomarker research, scientific publications and presentations, clinical site and recruitment news, as well as articles in the media that feature the study. Sign up for email updates to be notified when new posts are added.

PPMI News Get updates: Email RSS

Recent Posts

Interview on RNA in PPMI with Dr. Van Keuren-Jensen

Jan 27, 2020

Today, we will be asking Dr. Van-Keuren Jensen a few questions about RNA and hearing her insight as to why this vital element is something, we are focusing on in the Parkinson’s Progression Markers Initiative (PPMI). Dr. Van Keuren-Jensen received her Ph.D. from Cold Spring Harbor Laboratory in New York, where she studied the role […]

Continue reading...

Recent Findings in PPMI

Jan 2, 2019

by Krishna Knabe The Michael J. Fox Foundation A group of authors led by PPMI’s principal investigator, Dr. Kenneth Marek, published baseline data from the study in the Annals of Clinical and Translational Neurology. The paper includes detailed biomarker signatures on the initial volunteer groups, which include patients with Parkinson’s disease, healthy controls and those who […]

Continue reading...

PPMI Study Enters a New Phase

Dec 20, 2018

by Krishna Knabe The Michael J. Fox Foundation The Parkinson’s Progression Markers Initiative (PPMI) has reached an important milestone: the study completed enrollment. We have now met the ambitious goal we set back in 2010 of enrolling 1,400 participants, including 600 with rare genetic mutations. PPMI is The Michael J. Fox Foundation’s landmark observational clinical […]

Continue reading...

PPMI Data Available: RNA Seq

Dec 11, 2018

by Bradford Casey, Ph.D. The Michael J. Fox Foundation The Parkinson’s Progression Markers Initiative (PPMI) includes a broad and comprehensive panel of measurements designed to improve our understanding of Parkinson’s disease (PD). One approach is analysis of the genome, the full complement of DNA present within the cells of the body. DNA is often considered […]

Continue reading...

PPMI Study Update Call – 6/14/18

Jun 8, 2018

PPMI Study Update Call Cerebrospinal Fluid Analysis Thursday, June 14 12-1 pm Eastern Time Brit Mollenhauer, MD Attending Neurologist, Head of Clinical Research PPMI Steering Committee Member Paracelsus-Elena Klinik Doug Galasko, MD Professor of Neurology PPMI Steering Committee Member University of California San Diego   PPMI participants are encouraged to call in to the next […]

Continue reading...

2018 PPMI Annual Meeting Summary

May 23, 2018

The 2018 PPMI Annual Investigator’s Meeting took place on May 2-3 in New York City.  There were more than 200 attendees present, including PPMI investigators and coordinators, Industry Scientific Advisory Board representatives, The Edmond J. Safra Fellowship in Movement Disorders fellows and fellowship directors, the PPMI Patient Committee, and the PPMI Steering Committee. This meeting […]

Continue reading...

Collaboration with Verily Aims to Deepen Parkinson’s Understanding through Digital Health Tools

May 11, 2018

Wearable sensors to monitor health-related measures like heart rate, glucose levels, or physical activity are helping people assess their own health and enabling research in treating and understanding chronic disease. The Michael J. Fox Foundation (MJFF) and Verily Life Sciences LLC, an Alphabet company, are collaborating to use wearable devices — in conjunction with clinic-based data and […]

Continue reading...

PPMI Steering Committee Paper Accepted to Movement Disorders Journal

Apr 5, 2018

We are excited to announce a recent research article using longitudinal data from PPMI has been accepted to Movement Disorders.  Members of the PPMI Steering Committee, including Dr. Tanya Simuni of Northwestern University, authored this publication on behalf of PPMI. The study, entitled Longitudinal Change of Clinical and Biological Measures in Early Parkinson’s Disease: Parkinson’s […]

Continue reading...

PPMI Study Update Call – 3/15/18

Feb 21, 2018

PPMI Study Update Call Thursday, March 15 12-1 pm Eastern Time Andrew Siderowf, MD, MSCE Professor of Neurology University of Pennsylvania Co-Principal Investigator of PPMI   PPMI participants are encouraged to call in to the next quarterly Study Update Call on Thursday, March 15, 2018 at 12 pm EST.  During this call, Dr. Andrew Siderowf, […]

Continue reading...

iPSC Sub-study Complete

Feb 20, 2018

PPMI is a nimble study designed to allow for quick adaptation to emerging needs in the Parkinson’s disease (PD) research field.  In response to increased interest from researchers in well-characterized induced pluripotent stem cells (iPSCs) adult cells capable of giving rise to any human cell type, PPMI launched the Golub Capital iPSC Sub-Study in collaboration […]

Continue reading...